The Food and Drug Administration (FDA) of the United States has now granted the emergency use authorization to a new at-home corona virus tests amid the shortages of the testing kits and increasing rates of the corona virus cases in the United States.
In the previous month, the US FDA has also announced that, the agency had also issued a revised EUA to the real-time RT-PCR test of Amazon, which is used for the purpose detecting the SARS-CoV-2 for their use at the facilities of Amazon or at the respective homes of the people that are employing the kit of test collection unsupervised.
According to the US FDA, the company ‘Amazon’ has been planning the test as being a part of the overall corona virus preparedness along with the response program of the company. The EUA also said that, the individuals, who are now permitted for entering the facilities of Amazon under the health and safety measures are going to be invited for being tested periodically by using the Amazon covid-19 test.
The EUA has also continued that, for implementing the program of the covid-19 testing, the company ‘Amazon’ has now partnered with a third party provider of healthcare, who is going to be issuing the required prescriptions along with the orders of the individual test along with facilitating the reporting of the results for the purpose of testing the recipients.
Dr. Jeff Shuren, director of the Center for Devices and Radiological Health of US FDA said that, this program has been very beneficial for increasing the access to the rapid covid-19 tests by gathering the critical data of the companies that are needing to request the EUA and also entering the US market once they are authorized.
